When you develop and produce active pharma ingredients (API’s), there are always some impurities – identifying the chemical structure of the known ones is usually not a problem, but what about the unknown?

Whether the impurities are process-related or coming from the degradation of products they always need to be identified and classified accordingly.

With some of the best chemists in the industry using state of the art science and lab techniques, it now really is possible to identify the unidentified!

At QUINTA-ANALYTICA we offer structure elucidation, characterization, and full certification in both Research and Development (R&D) or Good Manufacturing Practice (GMP) mode. Our specialist labs are even able to do isotopically labeled compound enrichment.

With a global approach to business and multiple labs within central Europe, Quinta-Analytica is your true pharma partner.

Contact us today to learn more about the catalog of services we offer.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.